Bromday Versus Nevanac Eye Drops to Control Pain Following Photorefractive Keratectomy
Status: | Completed |
---|---|
Conditions: | Ocular |
Therapuetic Areas: | Ophthalmology |
Healthy: | No |
Age Range: | 21 - Any |
Updated: | 4/2/2016 |
Start Date: | May 2011 |
End Date: | May 2012 |
Contact: | Cheryl Swanson, COT |
Email: | eyes@virdieyemd.com |
Phone: | 3097885524 |
Bromday (Bromfenac Ophthalmic Solution)0.09% QD vs Nevanac (Nepafenac Ophthalmic Suspension) 0.1% TID for Control of Pain and Epithelial Healing Post (PRK)
This study will compare the effect of two topical non-steroidal antiinflammatory agents to
control pain after photorefractive keratectomy (PRK) eye surgery.
control pain after photorefractive keratectomy (PRK) eye surgery.
Inclusion Criteria:
- male or female at least 18 years of age,
- no other ocular studies with 15 days prior to dosing,
- BCVA 20/200 or better,
- return for study visits and follow instructions from investigator and staff,
- self administer test article
Exclusion Criteria:
- Ocular inflammation,
- hypersensitivity to bromfenac or nepafenac,
- any corneal pathology,
- have had radial keratotomy,
- corneal transplant or corneal refractive surgery in the last two years
We found this trial at
1
site
Click here to add this to my saved trials
